Senores Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth shows a consistent upward trend over the last four quarters, indicating robust demand for products.
Operating margin improved significantly in the latest quarter, reflecting better cost management and operational efficiency.
Net profit margin increased, showcasing effective pricing strategies and a favorable market position amidst industry challenges.

NEGATIVES

Raw material costs rose sharply, impacting profitability despite revenue growth in the latest quarter.
Competitive pressures intensified, leading to increased marketing expenses that could affect future margins.
Debt levels have increased, raising concerns about financial stability and potential cash flow issues moving forward.

Field	Dec 24	Mar 25	Jun 25
Revenue	103.02	114.21	137.99
Expenses	87.69	105.30	114.86
Operating Profit	15.33	8.91	23.13
Other Income	5.16	11.77	3.36
Interest	6.16	5.30	5.04
Depreciation	4.20	5.23	5.99
Profit Before Tax	20.49	20.68	26.49
Tax	4.06	2.71	5.31
Net Profit	16.43	17.97	21.18
Eps in Rs	5.04	3.81	4.60